• Products
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Trading Platforms
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Trading Platforms
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Share Market Today
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Stockshaala
    Basics of Stock Market
    Introduction to Fundamental Analysis
    Introduction to Technical Analysis
    Derivatives, Risk management & Option Trading Strategies
    Personal Finance
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Stockshaala
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement
​

Max Healthcare Institute Ltd's Q4FY25 Quarter Results

Max Healthcare Institute Ltd's revenue increased 17.0% YoY
  • 21 May 2025
  • Max Healthcare Institute Ltd reported a 22.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 17.0%.
  • Its expenses for the quarter were down by 25.5% QoQ and up 18.7% YoY.
  • The net profit increased 5.3% QoQ and increased 0.2% YoY.
  • The earnings per share (EPS) of Max Healthcare Institute Ltd stood at 2.6 during Q4FY25.
(₹ crores) Q4FY25 Q3FY25 Q4FY24 QoQ (%) YoY (%)
Total Income
1468.15
1901.61
1254.73
-22.8%
17.0%
Total Expenses
1132.42
1519.11
954.05
-25.5%
18.7%
Profit Before Tax
335.73
308.87
300.68
8.7%
11.7%
Tax
84.19
70.07
49.76
20.2%
69.2%
Profit After Tax
251.54
238.80
250.92
5.3%
0.2%
Earnings Per Share
2.60
2.40
2.60
8.3%
0.0%

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Max Healthcare Institute Ltd is a prominent player in the healthcare industry, primarily focusing on providing healthcare services. The company operates a chain of hospitals and healthcare facilities across India, catering to a wide range of medical needs. As of the last available data, the company has been actively expanding its operations to enhance its service offerings and reach. While specific recent developments beyond October 2023 are not available, Max Healthcare Institute has been known for its emphasis on technological integration in healthcare services and strategic partnerships to improve healthcare delivery. The company is recognized for its comprehensive medical services, including advanced diagnostics, surgery, and patient care.

For the fourth quarter of FY25, Max Healthcare Institute Ltd reported total income of ₹1468.15 crores, a decrease of 22.8% compared to the previous quarter (Q3FY25) where the total income was ₹1901.61 crores. However, when compared to the fourth quarter of the previous fiscal year (Q4FY24), there is a 17.0% increase from ₹1254.73 crores. This year-over-year growth indicates an upward trend in the company's revenue on an annual basis, despite the quarter-over-quarter decline. This fluctuation in revenue suggests variability in income, which is a common occurrence in the healthcare sector due to seasonal and operational dynamics.

Profitability for Max Healthcare Institute Ltd showed an improvement in Q4FY25, with the Profit Before Tax (PBT) rising to ₹335.73 crores, marking an 8.7% increase from the previous quarter's profit of ₹308.87 crores. When compared to the same quarter last year, PBT rose by 11.7% from ₹300.68 crores, reflecting consistent growth in profitability. The Profit After Tax (PAT) for Q4FY25 stood at ₹251.54 crores, which is a 5.3% increase from the previous quarter's ₹238.80 crores, and a marginal year-over-year increase of 0.2% from ₹250.92 crores in Q4FY24. The tax expense for Q4FY25 was ₹84.19 crores, showing a significant increase of 20.2% from the previous quarter and 69.2% year-over-year, which impacts the net profit figures.

The total expenses for Q4FY25 amounted to ₹1132.42 crores, reflecting a decrease of 25.5% from the previous quarter's expenses of ₹1519.11 crores. Compared to Q4FY24, expenses increased by 18.7% from ₹954.05 crores, indicating a year-over-year rise in operational costs. Earnings Per Share (EPS) remained stable year-over-year at ₹2.60, although there was an 8.3% increase from the previous quarter's EPS of ₹2.40. This stability in EPS year-over-year, despite fluctuations in income and expenses, suggests a controlled management of share earnings. Further detailed financial ratios such as P/E ratio, debt-to-equity ratio, and current ratio require additional data beyond what is provided, as they depend on market values and balance sheet specifics not included in the financial data.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -